Understanding how a key protein controls immune cell responses
BACH1 as a novel pioneer repressor in macrophages: impact on homeostasis and inflammation
This research explores how a protein called BACH1 helps control our immune cells, called macrophages, to manage inflammation and keep our bodies healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11159697 on NIH RePORTER |
What this research studies
Our immune system relies on specialized cells called macrophages to fight off infections and manage inflammation. This project aims to understand how a specific protein, BACH1, acts as a master controller within these macrophages. We believe BACH1 helps to 'bookmark' certain genes, ensuring that the immune response is properly turned on and off. By studying this process, we hope to uncover new ways our bodies regulate inflammation and maintain balance. This work could lead to a better understanding of how to treat diseases where inflammation goes awry.
Who could benefit from this research
Good fit: This foundational research does not directly involve patients, but future studies building on this work could benefit individuals with chronic inflammatory conditions or immune disorders.
Not a fit: Patients seeking immediate treatment options would not directly benefit from this basic science research, as it focuses on fundamental biological mechanisms.
Why it matters
Potential benefit: If successful, this research could lead to new insights into how inflammatory diseases develop and potentially new targets for treatments that restore proper immune function.
How similar studies have performed: This project challenges existing views on inflammatory gene regulation, suggesting a novel role for the BACH1 protein that is currently being explored.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Nagy, Laszlo — Johns Hopkins University
- Study coordinator: Nagy, Laszlo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.